국회도서관 서비스 이용에 대한 안내를 해드립니다.
검색결과 (전체 1건)
원문 있는 자료 (1)열기
원문아이콘이 없는 자료는 국회도서관에 방문하여 책자로만 이용이 가능합니다.
I. Introduction 6
II. Materials and Methods 9
1. Study Design 9
2. Viruses 9
3. Introduction of the reversed X-187 virus 10
4. Hemagglutination inhibition assays 10
5. Egg passages of the X-187 and reversed X-187 virus 11
6. Cell passages of the reversed X-187 virus 11
7. Sequence analysis 11
8. Statistical analysis 12
III. Results 13
1. Antigenicity of the X-187 (A/H3N2) vaccine virus 13
2. Mutation of the X-187 (A/H3N2) vaccine virus 18
3. Mutation of the reversed X-187 vaccine virus 20
IV. Discussion 23
V. Conclusion 26
Table 1. Geometric mean HI titers and seroprotection rates (%) of the randomly selected 80 influenza vaccinees, of which homologous HI titers... 17
Figure 1. Distribution of HI antibody titers of 2011-12 influenza vaccinees against X-187 vaccine virus, vaccine prototype A/Victoria/210/2009 virus... 14
Figure 2. Geometric mean HI titers of 2011-12 influenza vaccinees against X-187 vaccine virus, vaccine prototype A/Victoria/210/2009 virus... 15
Figure 3. Seroprotection rates (%) of 2011-12 influenza vaccinees against X-187 vaccine virus, vaccine prototype A/Victoria/210/2009 virus and the... 16
Figure 4. Hemagglutinin amino acid sequences of 2011-12 egg-adapted A/Victoria/210/2009 X-187 high growth reassortant vaccine strain and... 19
Figure 5A. Hemagglutinin amino acid sequences of the reversed X-187 virus and sequentially subcultured viruses in eggs: Serine at residue 244... 21
Figure 5B. Hemagglutinin amino acid sequences of the reversed X-187 virus and sequentially subcultured viruses in cells: Serine at residue 244... 22
Background: The 2011-12 seasonal trivalent inactivated influenza vaccine was overall poorly protective against influenza A (H3N2) infection. We evaluated whether the low vaccine effectiveness (VE) in this season was associated with mutation in hemagglutinin (HA) of the egg-derived vaccine strain. Additionally, it was investigated whether the egg-derived vaccine seed strain obtains further mutations in the receptor binding site while being propagated in the eggs through the manufacturing process.
Materials and methods: We performed hemagglutination inhibition (HI) assays and compared the reactivities of human sera from the recipients of 2011-12 influenza vaccination against the X-187 vaccine seed virus (with Ser-to-Thr mutation at residue 228 [Ser228Thr]), vaccine prototype virus and the reversed X-187 vaccine virus (with Thr228Ser).And the reactivities of the anti-sera from the 2011-12 influenza vaccinees against circulated influenza viruses were assessed. We analysed the sequences of the HAs of repetitively propagated influenza vaccine viruses and compared it to the sequence of the original vaccine virus.
Results: The reactivities of human sera from the 2011-12 influenza-vaccinated subjects against the X-187 vaccine virus, vaccine prototype virus and the reversed X-187 vaccine virus were not statistically different, as measured by geometric mean titers (GMT) [177 (95% CI: 151-208) vs. 150 (95% CI: 128-177) vs. 142 (95% CI: 120-167); P ＝ 0.139]. (Fig. 3) The seroprotection rates of 2011-12 influenza vaccinees against three kinds of viruses were 99.2% (X-187 vaccine virus group), 98.5% (vaccine prototype virus group) and 98.5% (reversed X-187 virus group) (P ＝ 0.582). (Fig. 4) The GMTs and the seroprotection rates of 80 influenza vaccinees during the 2011-12 season against the circulated A/H3N2 influenza viruses were much lower compared with those of the X-187 vaccine virus, vaccine prototype virus and reversed X-187 vaccine virus. (Table 1) Any further mutation did not occur in the receptor binding site of the X-187 and reversed X-187 virus while being propagated in the eggs.
Conclusion: The low influenza VE during the 2011-12 season was may be the result from mismatch of the vaccine strains with circulating viruses rather than from the development of mutation in the egg-derived vaccine virus. In addition, it is thought that eggs are still able to function as the economical and practical vaccine production substrate.
원문구축 및 2018년 이후 자료는 524호에서 직접 열람하십시요.
도서위치안내: / 서가번호:
우편복사 목록담기를 완료하였습니다.
* 표시는 필수사항 입니다.
* 주의: 국회도서관 이용자 모두에게 공유서재로 서비스 됩니다.
국회전자도서관에 오신 것을 환영합니다. 로그인을 하시려면 아이디와 비밀번호를 입력해주세요.
모바일 간편 열람증으로 입실한 경우 회원가입을 해야합니다.
공용 PC이므로 한번 더 로그인 해 주시기 바랍니다.
아이디 또는 비밀번호를 확인해주세요